These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8836371)

  • 1. Use of tilmicosin for treatment of pasteurellosis in rabbits.
    McKay SG; Morck DW; Merrill JK; Olson ME; Chan SC; Pap KM
    Am J Vet Res; 1996 Aug; 57(8):1180-4. PubMed ID: 8836371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of in vitro minimum inhibitory concentrations of tilmicosin against Mannheimia haemolytica and Pasteurella multocida and in vivo tilmicosin treatment outcome among calves with signs of bovine respiratory disease.
    McClary DG; Loneragan GH; Shryock TR; Carter BL; Guthrie CA; Corbin MJ; Mechor GD
    J Am Vet Med Assoc; 2011 Jul; 239(1):129-35. PubMed ID: 21718206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory benefits of tilmicosin in calves with Pasteurella haemolytica-infected lungs.
    Chin AC; Morck DW; Merrill JK; Ceri H; Olson ME; Read RR; Dick P; Buret AG
    Am J Vet Res; 1998 Jun; 59(6):765-71. PubMed ID: 9622749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical field trials with tilmicosin phosphate in feed for the control of naturally acquired pneumonia caused by Actinobacillus pleuropneumoniae and Pasteurella multocida in swine.
    Moore GM; Basson RP; Tonkinson LV
    Am J Vet Res; 1996 Feb; 57(2):224-8. PubMed ID: 8633813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of experimentally induced pneumonic pasteurellosis of young calves with tilmicosin.
    Morck DW; Merrill JK; Gard MS; Olson ME; Nation PN
    Can J Vet Res; 1997 Jul; 61(3):187-92. PubMed ID: 9242998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The minimum inhibitory concentration of tilmicosin and tylosin for mycoplasma gallisepticum and Mycoplasma synoviae and a comparison of their efficacy in the control of Mycoplasma gallisepticum infection in broiler chicks.
    Jordan FT; Horrocks BK
    Avian Dis; 1996; 40(2):326-34. PubMed ID: 8790882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tilmicosin reduces lipopolysaccharide-stimulated bovine alveolar macrophage prostaglandin E(2) production via a mechanism involving phospholipases.
    Lakritz J; Tyler JW; Marsh AE; Romesburg-Cockrell M; Smith K; Holle JM
    Vet Ther; 2002; 3(1):7-21. PubMed ID: 12050824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella spp. associated with bovine respiratory disease.
    Shryock TR; White DW; Staples JM; Werner CS
    J Vet Diagn Invest; 1996 Jul; 8(3):337-44. PubMed ID: 8844577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella multocida and Actinobacillus pleuropneumoniae associated with porcine respiratory disease.
    Shryock TR; Staples JM; DeRosa DC
    J Vet Diagn Invest; 2002 Sep; 14(5):389-95. PubMed ID: 12296390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repromicin derivatives with potent antibacterial activity against Pasteurella multocida.
    McFarland JW; Hecker SJ; Jaynes BH; Jefson MR; Lundy KM; Vu CB; Glazer EA; Froshauer SA; Hayashi SF; Kamicker BJ; Reese CP; Olson JA
    J Med Chem; 1997 Mar; 40(6):1041-5. PubMed ID: 9083494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of calf pneumonia with tilmicosin.
    Fodor L; Varga J; Gallowitsch F; Horváth-Papp I; Miklós G; Lajcsák A; Harmath A
    Acta Vet Hung; 1993; 41(1-2):41-9. PubMed ID: 8116500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of respiratory tract disease on pharmacokinetics of tilmicosin in rats.
    Modric S; Webb AI; Davidson M
    Lab Anim Sci; 1999 Jun; 49(3):248-53. PubMed ID: 10403438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary disposition of tilmicosin in foals and in vitro activity against Rhodococcus equi and other common equine bacterial pathogens.
    Womble A; Giguère S; Murthy YV; Cox C; Obare E
    J Vet Pharmacol Ther; 2006 Dec; 29(6):561-8. PubMed ID: 17083461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of tilmicosin in equine tissues and plasma.
    Clark C; Dowling PM; Ross S; Woodbury M; Boison JO
    J Vet Pharmacol Ther; 2008 Feb; 31(1):66-70. PubMed ID: 18177321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a new macrolide antibiotic (tilmicosin) on pneumonia experimentally induced in calves by Mycoplasma bovis and Pasteurella haemolytica.
    Gourlay RN; Thomas LH; Wyld SG; Smith CJ
    Res Vet Sci; 1989 Jul; 47(1):84-9. PubMed ID: 2772410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postantibiotic effects and postantibiotic sub-MIC effects of erythromycin, roxithromycin, tilmicosin, and tylosin on Pasteurella multocida.
    Lim J; Yun H
    Int J Antimicrob Agents; 2001 Jun; 17(6):471-6. PubMed ID: 11397617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effectiveness of tilmicosin in respiratory diseases of swine].
    Binder S; Le NB; Berner H; Bauer J
    Berl Munch Tierarztl Wochenschr; 1993 Jan; 106(1):6-9. PubMed ID: 8431202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Pasteurella haemolytica from cattle.
    Stephens CP; Blackall PJ; Wade LK; Lowe LB
    Aust Vet J; 1993 Oct; 70(10):391-2. PubMed ID: 8257321
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of tilmicosin in the control of experimental Mycoplasma gallisepticum infection in chickens.
    Kempf I; Reeve-Johnson L; Gesbert F; Guittet M
    Avian Dis; 1997; 41(4):802-7. PubMed ID: 9454912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tilmicosin on acute undifferentiated respiratory tract disease in newly arrived feedlot cattle.
    Vogel GJ; Laudert SB; Zimmermann A; Guthrie CA; Mechor GD; Moore GM
    J Am Vet Med Assoc; 1998 Jun; 212(12):1919-24. PubMed ID: 9638194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.